People on the Move: Ali Soleymannezhad, Chief Commercial Officer, MaxCyte
MaxCyte appoints Ali Soleymannezhad as Chief Commercial Officer, where he will spearhead the company’s commercial operations to enhance the adoption of the ExPERT Platform and support advancements in Cell and Gene Therapy.
October 10, 2024
| BioBuzz has been connecting the life science workforce since 2009. We’ve built an expansive community in the Mid-Atlantic with a national readership that spans from Massachusettes to Florida, and New York to California. For our next chapter, we’re building a proprietary talent logistics model to help employers source and hire life science talent. Learn more. |
MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering-focused company providing enabling platform technologies to advance the discovery, development, and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, announced the appointment of Ali Soleymannezhad as Chief Commercial Officer, effective as of September 11, 2024.
In his new role, Soleymannezhad will lead MaxCyte’s commercial operations to increase adoption of the ExPERT Platform, provide best-in-class scientific, technical, and regulatory support to customers, and expand the Company’s market impact in Cell and Gene Therapy. Prior to his role as Chief Commercial Officer, Soleymannezhad was the Executive Vice President of Bioprocessing, where he led global product development and marketing strategy for MaxCyte’s bioprocessing business.
“I am delighted to promote Ali to the role of Chief Commercial Officer,” said Maher Masoud, President and CEO of MaxCyte. “His diverse experience, skills, and leadership at MaxCyte as Executive Vice President of Bioprocessing have strengthened our organization’s product development and commercial strategies. We look forward to working alongside Ali as he leads our commercial efforts to drive future growth at MaxCyte.”
About Ali Soleymannezhad
Ali Soleymannezhad brings 20 years of technical sales, marketing, and product development experience to his new role. Prior to Executive Vice President of Bioprocessing at MaxCyte, he served as Executive Vice President for the Separations and Purification business at Tosoh Bioscience and oversaw a team of 140 employees across four global manufacturing, development, and commercial sites. Soleymannezhad was also Vice President of Global Marketing and Business Development and Director of Sales and Marketing-Americas at Tosoh and served on the board of Semba Biosciences.
“I am excited to apply my experience in sales and marketing and global business strategy to MaxCyte’s commercial efforts,” said Ali Soleymannezhad, CCO of MaxCyte. “I look forward to working with our executive team to continue MaxCyte’s commitment to supporting our customer’s Cell and Gene therapy work in research, through the clinic, and beyond.”
About MaxCyte
At MaxCyte, we pursue cell engineering excellence to maximize the potential of cells to improve patients’ lives. We have spent more than 20 years honing our expertise by building best-in-class platforms, perfecting the art of the transfection workflow, and venturing beyond today’s processes to innovate tomorrow’s solutions. Our ExPERT™ platform, which is based on our Flow Electroporation® technology, has been designed to support the rapidly expanding cell therapy market and can be utilized across the continuum of the high-growth cell therapy sector, from discovery and development through commercialization of next-generation, cell-based medicines. The ExPERT family of products includes: four instruments, the ATx™, STx™, GTx™ and VLx ™; a portfolio of proprietary related processing assemblies or disposables; and software protocols, all supported by a robust worldwide intellectual property portfolio. By providing our partners with the right technology platform, as well as scientific, technical and regulatory support, we aim to guide them on their journey to transform human health. Learn more at maxcyte.com and follow us on X and LinkedIn.
- About the Author
- Latest Posts
BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.
